Hannah Valantine Insider Trades & Stock Holdings

BridgeBio Pharma, Inc. · Latest filing Jun 23, 2026

Hannah Valantine at BridgeBio Pharma, Inc. has 4 Form 4 trades on file since Jun 15, 2026 across 2 companies. Open-market activity: 0 purchases ($0) and 2 sales ($430.28K), net -$430.28K. Latest filing: disposed of 2.20K shares of $BBIO on Jun 23, 2026 at $68.57.

Trades on file
4
Open-market bought
$0
Open-market sold
$430.28K
Net open-market
-$430.28K
Latest filing
Jun 23, 2026

All insider trades by Hannah Valantine

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$BBIO Sell (Open-market sale) 10b5-1 2.20K $68.57 $150.58K +8.5%+20.8% —
$BBIO Sell (Option exercise) 2.81K $0 — +4.5%+19.9% Read
$BBIO Buy (Option exercise) 2.81K $41.73 $117.18K +4.5%+19.9% —
$CDNA Sell (Open-market sale) 10b5-1 12.10K $23.11 $279.70K +4.0%+23.5% Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hannah Valantine traded

Frequently asked questions

Has Hannah Valantine been buying or selling stock?

Hannah Valantine has 0 open-market purchases and 2 open-market sales on file, net -$430.28K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hannah Valantine's latest insider trade?

disposed of 2.20K shares of $BBIO on Jun 23, 2026 at $68.57.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text